A body of evidence suggests that this ACE2 enzymatic activity serves to counteract effects mediated by angiotensin converting enzyme (ACE), and it has been proposed that imbalances in ACE/ACE2 activity contribute to diseases such as hypertension, progressive renal disease, and diabetes, all of which have been associated with risk for severe COVID-19 [18]. Here, ACE2 is linked to Hypertension.